Each tablet contains Diclofenac Potassium 50 mg and Serratiopeptidase 10 mg.

Divon S is a combination of Diclofenac Potassium, a nonsteroidal anti-inflammatory drug (NSAID), and Serratiopeptidase, a proteolytic enzyme with anti-inflammatory and anti-edematous properties. This combination provides rapid relief from pain and inflammation while helping reduce tissue swelling associated with trauma, surgery, and musculoskeletal injuries. It improves patient comfort, promotes mobility, and supports faster recovery from acute inflammatory conditions.

Divon S is indicated for the treatment of acute pain in adults, particularly when pain is associated with inflammation and soft tissue swelling. It is commonly prescribed for musculoskeletal injuries, post-traumatic inflammation, postoperative pain, dental pain, and other acute inflammatory conditions requiring both analgesic and anti-edematous therapy.

Diclofenac Potassium is a nonsteroidal anti-inflammatory drug (NSAID) that exerts anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the production of prostaglandins responsible for pain, inflammation, and fever. Serratiopeptidase is a proteolytic enzyme with anti-inflammatory properties that helps reduce inflammatory edema by breaking down inflammatory mediators and protein deposits, making it particularly beneficial in reducing post-traumatic and postoperative swelling.

The recommended dosage is one to two tablets daily, or as directed by the treating physician.

Divon S is contraindicated in patients with known hypersensitivity to diclofenac, serratiopeptidase, or any component of the formulation. It should not be administered to patients who have experienced asthma, urticaria, or allergic-type reactions following aspirin or other NSAIDs. The product is also contraindicated for the management of perioperative pain associated with coronary artery bypass graft (CABG) surgery.